Abstract
At present, several experiments have been carried out to study the changes in total arsenic content of realgar and its prescription, but few researches on its form and valence. We evaluated the change in arsenic species concentration in realgar from the perspective of absorption by using an in vitro dissolution study, an in vivo unidirectional intestinal perfusion study, transmembrane transport in Caco-2 cells, and a pharmacokinetic study in rats. In the gastrointestinal tract, arsenic species are mainly present inorganic forms of AsIII and AsV. The cumulative dissolution rates of soluble arsenic in 4 h artificial gastric fluid and 8 h artificial intestinal fluid were 21.99% and 59.20%, respectively. The P (app) values of soluble arsenic in realgar in the duodenum, jejunum, and ileum of rats were 5.4 × 10(-3), 6.1 × 10(-3) and 5.8 × 10(-3) cm/min, respectively. In the process of small intestine perfusion, the AsIII of realgar was partially converted into AsV in the duodenum and jejunum. As the transport time increased, the transmembrane transport rate and P (app) value of soluble arsenic in realgar were increased in Caco-2 cells, and it also suggested that arsenic species may be passively transported across the Caco-2 cell monolayer. The C (max) and AUC ((0-24)) of AsIII, AsV, and DMA in plasma of realgar were 41.26 ng L(-1)/343.977 ng h mL(-1), 21.626 ng L(-1)/47.310 ng h mL(-1), and 2.372 ng L(-1)/30.429 ng h mL(-1), respectively. T (max) and MRT ((0-∞)) of AsIII, AsV, and DMA were 2.571 h/9.649 h, 0.393 h/2.790 h, and 3.143 h/23.145 h, respectively. It is hoped to provide a basis for clarifying the arsenic species in realgar.